Enspryng

(satralizumab)
1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng]
NO BOXED WARNING

Dosage & administration

drug label

Enspryng prescribing information

samples

Request Enspryng samples

Online Sample Form
Learn More

prior authorization

Enspryng prior authorization resources

Most recent Enspryng prior authorization forms

View By Payer
Verified: Nov 26, 2023Cigna - Enspyng Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Appeals
Learn More

Benefits investigation

Enspryng Start Form
Enspryng Start Form - Online
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

pharmacy

Enspryng preferred pharmacy

Pharmacy List

financial assistance

Enspryng financial assistance options

Co-pay savings program

commercial only
Enspryng Start Form
Enspryng Start Form - Online
Enroll in Patient Savings Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Enspryng Start Form
Enspryng Start Form - Online
Genentech Patient Assistance Program Application - Prescriber Form
Learn More

patient education

Enspryng patient education

Getting started on Enspryng

Instructions For Use: Neuromyelitis Optica Spectrum Disorder (NMOSD)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

About Enspryng
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Enspryng
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Patient Navigators
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Enspryng FAQs

Is there a pregnancy exposure registry for ENSPRYNG?Yes, there is a pregnancy exposure registry for ENSPRYNG that monitors pregnancy outcomes in women exposed to the drug during pregnancy. Healthcare providers are encouraged to register patients, and pregnant women are encouraged to register themselves by calling 1-833-277-9338.
What is the risk of using ENSPRYNG during pregnancy?There are no adequate data on the developmental risk associated with the use of ENSPRYNG in pregnant women. In the U.S. general population, the estimated background risk of major birth defect and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown.
Is satralizumab-mwge present in human milk?No information is available on the presence of satralizumab-mwge in human milk. Satralizumab-mwge was excreted in the milk of lactating monkeys administered satralizumab-mwge throughout pregnancy. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for ENSPRYNG and any potential adverse effects on the breastfed infant from ENSPRYNG or from the underlying maternal condition.
Is ENSPRYNG safe and effective for use in pediatric patients?Safety and effectiveness in pediatric patients have not been established.
Are there any specific considerations for dosing ENSPRYNG in elderly patients?Clinical studies of ENSPRYNG did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently from younger patients. In general, caution should be used when dosing the elderly, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant diseases or other drug therapy.
FAQ Data Source